
Deep Health AI India Ltd is Rated Strong Sell
2026-07-09 10:10:55Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Deep Health AI India Ltd is Rated Strong Sell
2026-06-19 10:11:29Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 February 2026, reflecting a change from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 19 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Deep Health AI India Ltd Valuation Shifts Signal Heightened Price Risk
2026-06-17 08:00:24Deep Health AI India Ltd, a micro-cap player in the Gems, Jewellery and Watches sector, has experienced a notable shift in its valuation parameters, moving from expensive to very expensive territory despite a challenging market backdrop and subdued returns relative to benchmarks like the Sensex.
Read full news article
Deep Health AI India Q4 FY26: Severe Loss Triggers 78% Crash from Peak
2026-05-30 20:18:18Deep Health AI India Ltd., a micro-cap company operating in the gems and jewellery sector with recent forays into pharmaceutical consultancy, reported a devastating fourth quarter for FY26, posting a consolidated net loss of ₹4.51 crores compared to a profit of ₹0.35 crores in the same quarter last year. The catastrophic 1,388.57% year-on-year decline in profitability sent the stock tumbling to ₹2.21, down 78.52% from its 52-week high of ₹10.29, with the company's market capitalisation shrinking to just ₹34.00 crores.
Read full news article
Deep Health AI India Ltd is Rated Strong Sell
2026-05-27 10:11:05Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Deep Health AI India Ltd is Rated Strong Sell
2026-05-13 10:10:52Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Deep Health AI India Ltd Valuation Shift Signals Price Attractiveness Change
2026-04-30 08:00:20Deep Health AI India Ltd, a micro-cap player in the Gems, Jewellery and Watches sector, has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. Despite a modest price-to-earnings (P/E) ratio of 5.95, the company’s stock performance continues to lag behind broader market indices, raising questions about its price attractiveness relative to peers and historical benchmarks.
Read full news article
Deep Health AI India Ltd is Rated Strong Sell
2026-04-29 10:10:36Deep Health AI India Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Deep Health AI India Ltd Valuation Shifts Signal Heightened Price Risk
2026-04-24 08:00:19Deep Health AI India Ltd, a micro-cap player in the Gems, Jewellery and Watches sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive classification. Despite a modest uptick in share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages suggest caution for investors amid deteriorating fundamentals and a strong sell rating upgrade.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Jul-2026 | Source : BSEIn accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 based on the certificate received from M/s. MUFG Intime India Pvt Ltd. (RTA of the Company) which is enclosed herewith we hereby confirm in relation with the securities received for Dematerialization/Re-materialization that: a) The securities received from depository participants for Dematerialization/ Rematerialization were confirmed (accepted/ rejected) to the depositories; b) The securities comprised in the said Certificate(s) of Security have been listed on the Stock Exchanges; and c) The said Certificate (s) after due verification have been mutilated and cancelled and the name of the depository has been substituted in our records (i.e. in register of members) as the registered owner within stipulated time limit.
Clarification With Respect To Proposed Acquisition Of Land.
13-Jul-2026 | Source : BSEThis is to inform you that the Company had proposed the acquisition of land and in furtherance thereof entered into a Memorandum of Understanding (MoU) dated March 06 2026 with M/s. Elegant Floriculture & Agrotech (India) Limited for the proposed acquisition of land situated at Gat No. 358 Village Mouje Kashal Taluka - Maval District Pune - 412106 Maharashtra India admeasuring 49100 sq. mtr. Pursuant to the terms of the MoU the Company has made an aggregate advance payment of Rs. 28500000/- towards the proposed acquisition. The said amount was remitted in 10 tranches with the last tranche of the aforesaid advance payment being made on June 06 2026. The proposed acquisition is for the development of a naturopathy centre and a holistic rejuvenation centre including cultivation of medicinal plant species with a focus on organic and herb-based wellness and agro-tourism aimed at promoting preventive healthcare.
Clarification And Submission Of Revised Audit Report For The Financial Year Ended March 31 2026
13-Jul-2026 | Source : BSEThis is to inform you that the Board of Directors of the Company at its meeting held on May 29 2026 approved the Audited Standalone and Consolidated Financial Results for the financial year ended March 31 2026 which were duly submitted to the Stock Exchange. Subsequently it was observed that the Auditors Report forming part of the Audited Consolidated Financial Results inadvertently did not mention the names of the entities covered under the Consolidated Financial Statements as required in the report format. The omission was purely inadvertent and does not have any impact on the financial results or the audit opinion. Accordingly we are submitting herewith the revised Auditors Report incorporating the aforesaid details. We wish to clarify that there is no change in the Audited Standalone and Consolidated Financial Results as already submitted to the Stock Exchange.
Corporate Actions
No Upcoming Board Meetings
Deep Health AI India Ltd has declared 10% dividend, ex-date: 07 Nov 25
Deep Health AI India Ltd has announced 1:10 stock split, ex-date: 20 Jan 23
No Bonus history available
Deep Health AI India Ltd has announced 2:1 rights issue, ex-date: 29 Aug 25






